Home
Service
Pathology
OUTSOURCE
EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE (Z101)-Delhi
Service
Pathology
OUTSOURCE
EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE (Z101)-Delhi
OUTSOURCE
EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE (Z101)
About This Test
This profile helps to track the progression of Myeloma and the response to treatment. Detection of minimal residual disease in Multiple Myeloma predicts outcome, helps identify impending relapse and enables early intervention, better post transplant surveillance and better clinical management of patients.
Test Parameters (1)
- EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE
Home Collection
✓ Available
Reports Available In
2 Days
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
No special preparation required
The Multiple Myeloma Comprehensive Profile is important because it provides a complete evaluation of the disease, helping in diagnosis, treatment planning, and monitoring.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
